Daily startup and blockchain data-wiki with interviews, Q&A's & discussions about funding rounds & investors.

RaisedToday moderators manually update and approve wiki edits - check back every 1-2h for approved submissions.

Contributed by laura998

Vertex Pharmaceuticals

5 Disclosed Funding Rounds $606,197,225

4 Participating Investments $42,706,732


Pharmaceutical, Health Care, Biotechnology, Medical

Vertex Pharmaceuticals is focused on the discovery and development of small molecule drugs for the treatment of serious diseases.

Boston, Massachusetts, United States, North America (GB)

Organizations in Boston in Pharmaceutical,
Organizations in Boston in Health Care,
Organizations in Boston in Biotechnology,
Organizations in Boston in Medical,
Organizations in Massachusetts in Pharmaceutical,
Organizations in Massachusetts in Health Care,
Organizations in Massachusetts in Biotechnology,
Organizations in Massachusetts in Medical,
Organizations in United States in Pharmaceutical,
Organizations in United States in Health Care,
Organizations in United States in Biotechnology,
Organizations in United States in Medical,
Organizations in North America in Pharmaceutical,
Organizations in North America in Health Care,
Organizations in North America in Biotechnology,
Organizations in North America in Medical

Investors in Boston in Pharmaceutical,
Investors in Boston in Health Care,
Investors in Boston in Biotechnology,
Investors in Boston in Medical,
Investors in Massachusetts in Pharmaceutical,
Investors in Massachusetts in Health Care,
Investors in Massachusetts in Biotechnology,
Investors in Massachusetts in Medical,
Investors in United States in Pharmaceutical,
Investors in United States in Health Care,
Investors in United States in Biotechnology,
Investors in United States in Medical,
Investors in North America in Pharmaceutical,
Investors in North America in Health Care,
Investors in North America in Biotechnology,
Investors in North America in Medical

Greater Boston Area (0 Investors) (0 Startups), New England (0 Investors) (0 Startups), East Coast (0 Investors) (0 Startups), Northeastern US (0 Investors) (0 Startups)

Founded date 01, 1989

Founders Joshua Boger

Operating Status Active

Funding Stage IPO

Last Funding Type Post-IPO Equity

Also known as Vertex Pharmaceuticals Incorporated

Company Type For Profit


Facebook Link

Twitter Link

LinkedIN Link

Wikipedia Link

Vertex Pharmaceuticals is a biotechnology company committed to the discovery and development of breakthrough small molecule drugs for serious diseases. The Company's strategy is to commercialize its products both independently and in collaboration with major pharmaceutical companies. Vertex's product pipeline is focused on viral diseases, cystic fibrosis, inflammation, autoimmune diseases, cancer, and pain.

Date Round Raised Lead
December, 03, 2009 Post-IPO Equity $443,000,000 -------
September, 30, 2009 Post-IPO Equity $35,000,000 Janssen Belgium
September, 30, 2009 Post-IPO Debt $120,000,000 -------
March, 17, 2009 Venture - Series Unknown $2,397,225 -------
July, 17, 1989 Venture - Series Unknown $5,800,000 -------

Vertex Pharmaceuticals Participated In the Following Investment Rounds (4)

Organization Name Lead? Round Partners Participating Raise Date
Kymera Therapeutics No Series C ------- $102,000,000 March, 12, 2020
Genomics No Series B ------- $10,175,489 December, 09, 2018
Genomics Yes Series B ------- $32,531,243 August, 30, 2018
CRISPR Therapeutics Yes Series B ------- $25,000,000 April, 30, 2015

Vertex Pharmaceuticals Investors (9)

Investor Lead? Round Participating Raise Date Partners
J.P. Morgan Securities Inc. No Post-IPO Equity $443,000,000 December, 03, 2009 -------
Bank of America Merrill Lynch No Post-IPO Equity $443,000,000 December, 03, 2009 -------
Morgan Stanley No Post-IPO Equity $443,000,000 December, 03, 2009 -------
Goldman Sachs No Post-IPO Equity $443,000,000 December, 03, 2009 -------
Janssen Belgium Yes Post-IPO Equity $35,000,000 September, 30, 2009 -------
Norwest Venture Partners No Venture - Series Unknown $5,800,000 July, 17, 1989 -------
J.H. Whitney & Co No Venture - Series Unknown $5,800,000 July, 17, 1989 -------
New Enterprise Associates No Venture - Series Unknown $5,800,000 July, 17, 1989 -------
Greylock No Venture - Series Unknown $5,800,000 July, 17, 1989 -------